We have investigated the significance of the method of treatment on the oncological and functional outcomes and on the complications in 184 patients with soft-tissue sarcomas of the adductor compartment managed at three international centres. The overall survival at five years was 65% and was related to the grade at diagnosis and the size of the tumour. There was no difference in overall survival between the three centres. There was, however, a significant difference in local control with a rate of 28% in Centre 1 compared with 10% in Centre 2 and 5% in Centre 3.
We have investigated the significance of the method of treatment on the oncological and functional outcomes and on the complications in 184 patients with soft-tissue sarcomas of the adductor compartment managed at three international centres. The overall survival at five years was 65% and was related to the grade at diagnosis and the size of the tumour. There was no difference in overall survival between the three centres. There was, however, a significant difference in local control with a rate of 28% in Centre 1 compared with 10% in Centre 2 and 5% in Centre 3.
The overall mean functional score using the Toronto Extremity Salvage Score in 70 patients was 77% but was significantly worse in patients with wound complications or high-grade tumours. The scores were not affected by the timing of radiotherapy or the use of muscle flaps.
This large series of soft-tissue sarcomas of the adductor compartment has shown that factors influencing survival do not vary across the international boundaries studied, but that methods of treatment affect complications, local recurrence and function.
The adductor compartment of the thigh is the second most common site for soft-tissue sarcomas in the lower limbs. 1 Tumours in this location are frequently large before clinical detection and present particular challenges in surgical resection (Figs 1 and 2 ).
Whereas resection forms the mainstay of treatment, radiotherapy is an important adjunct for local control. [1] [2] [3] [4] [5] The combination of pre-and post-operative radiation and marginal excision produces similar results to amputation. [1] [2] [3] [4] Despite this, there remains controversy as to the optimal approach in the use of adjunctive radiotherapy. Radiotherapy protocols vary between centres, consisting broadly of either pre-or post-operative external beam treatment, or brachytherapy. 6 Complications following resection of a softtissue sarcoma in this site are frequent and increase morbidity. 7 One paper 1 observed that 43% of patients with soft-tissue sarcomas resected from the adductor compartment had moderate to major complications, including difficulties in wound-healing (Fig. 3) .
Very few studies have looked at soft-tissue sarcoma arising in specific anatomical compartments where outcomes are likely to differ. We have reviewed the results from three large international centres that treat soft-tissue sarcomas in the adductor compartment by different methods to see whether there is any difference in the oncological and functional outcomes. We also looked at the rates of wound complication. Centre 1 (The Royal Orthopaedic Hospital, Birmingham, United Kingdom) treats patients with high-grade softtissue sarcomas in the deep adductor compartment by excision and post-operative radiotherapy (66 Gy), whereas in Centre 2 (Mount Sinai Hospital, Toronto, Canada) many patients receive pre-operative radiotherapy (50 Gy) followed by excision. In Centre 3 (The Mayo Clinic, Rochester, Minnesota) most high-grade tumours are treated with pre-operative radio-and chemotherapy followed by resection, and lesions resected with close margins and those responding poorly to neoadjuvant therapies receive intra-operative radiotherapy. In the latter two centres, extensive excisions are often followed by free muscle flaps.
Patients and Methods
Between 1990 and 2001 the three centres treated 189 patients with a soft-tissue sarcoma of the adductor compartment. We define the term 'centre' as the place where the surgical treatment was undertaken, which may not be the same as the place where the adjuvant treatment was given. The series does not include Oncology patients who presented with local recurrence after previous treatment elsewhere, or those with metastases at the time of diagnosis or tumours superficial to the deep fascia. However, patients who had undergone an inadvertent biopsy or excision biopsy were included. Five patients, four from Centre 2 and one from Centre 1, were excluded because of unrecorded follow-up, leaving 184 in the study. Those lost to follow-up came from provinces far from the centres and were subsequently cared for locally.
We collected the following information retrospectively from the case records or the tumour databases at the respective centres: age at surgery, gender, maximum tumour dimension (cm), histological type and grade, status of the surgical margin, use and method of adjuvant radiotherapy or chemotherapy, the time to local recurrence after surgery, the time to systemic recurrence, and overall survival. The margins of excision were classified as either clear, with no tumour at the cut edge, or involved where tumour was present at this site. The descriptions of the margins were not modified from the information contained in the institutional database as the original observation was an important contributor to the decisions concerning the initial treatment employed. Data on wound complications and the length of stay following surgery were collected for each Wound dehiscence two weeks after operation. Wound complications are very common after resection of the adductor compartment. patient. A wound complication included a seroma, a purulent discharge and any complication requiring furthersurgical treatment. The functional scores were assessed using the Toronto Extremity Salvage Score 8 and were available only from Centres 1 and 2.
There were 94 men and 90 women. The mean age was 56 years (13 to 88). We identified 64, 62 and 58 patients as being eligible for the study in Centres 1, 2 and 3, respectively. The clinicopathological characteristics of these patients are summarised in Table I . Centre 1 had a significantly higher number of male patients (p = 0.003) and patients with larger tumours (Mann-Whitney U test, p = 0.004) than the other two institutions. Statistical analysis. Differences between the groups were assessed using the chi-squared test, the Mann-Whitney U test or the t -test. Overall survival and the rate of local recurrence were calculated using the Kaplan-Meier method, and the impact of prognostic factors was assessed using the logrank test. 9 Multivariate analysis was performed using Cox's proportional hazard method, 10 with variables being chosen using a forward conditional stepwise approach. Relative risks were calculated using a proportional hazards model, with only the noted covariate in the model. Significance was set at p < 0.05 for two-sided tests. The survival time was calculated from the time of diagnosis. End-points were taken as the time of death or the last documented time when the patient was known to be alive. Patients who died of unrelated causes were considered to have been censored.
Results
Treatment at the three centres. In Centre 1, all patients primarily underwent surgery and, for high-grade tumours, received post-operative external beam radiotherapy. The mean follow-up of patients was 54 months (5 to 144). In Centre 2, pre-operative radiotherapy alone was used in 23 patients (37%), whereas post-operative radiation was used in 27 (44%). Three patients (5%) had a combination of pre-and post-operative radiotherapy, while nine (14%) had none. The reason for this disparity was that for much of the study period patients were enrolled into a randomised trial comparing pre-and post-operative irradiation. 11 The current treatment at Centre 2 involves pre-operative irradiation administered at Princess Margaret Hospital, Toronto, which forms a conjoint programme with Mount Sinai Hospital. During the period of the study, patients with softtissue sarcoma at the Princess Margaret Hospital were treated exclusively by one of only two radiation oncologists, each with more than seven years of experience in the radiotherapy of sarcomas, who work in collaboration with the surgeons at the Mount Sinai Hospital. The hospital also uses formalised protocols for radiotherapy which are individually designed for each patient and were developed at the centre for the randomised trial referred to earlier. 11 For the period of this study these protocols were additionally enhanced by assessment by a third radiation oncologist working in a separate centre. Of these cases, 33 (53%) had reconstruction using a free or local muscle flap. The mean follow-up was 55 months (1 to 162). In Centre 3, 21 patients (36%) had pre-and intra-operative radiotherapy, five (9%) had intra-operative radiotherapy only, while six (10%) had intra-and post-operative radiotherapy and one (2%) had pre-, intra-, and post-operative treatment. Two patients (3%) had pre-and post-operative radiotherapy, while 12 (21%) were only treated pre-operatively, three (5%) only post-operatively and eight patients (14%) received none. Free muscle flaps were performed in 24 (41%) of cases. The mean follow-up was 52 months (2 to 143). Pre-operative chemotherapy was used in 24 patients (13%), five at Centre 1, none at Centre 2 and 19 at Centre 3. At Centre 1, chemotherapy was only used for patients with soft-tissue Ewing's tumours whereas at Centre 3 the most common indication was for malignant fibrous histiocytoma. Local control. The rate of local recurrence at five years in all patients from the three centres was 17%. The most significant predictive factors were an involved margin of excision (p = 0.0003) and the centre for treatment (p = 0.03). Table  II shows the uni-and multivariate analysis of prognostic factors for local recurrence for all patients. In Centre 1, local recurrence occurred in 18 patients (28%) at a mean time of 27.5 months (3 to 106) from diagnosis, with a rate of 28% at five years. Treatment involved amputation in three patients (4.5%) and re-excision in 15 (23%).
In Centre 2, six patients (10%) developed local recurrence by five years, whereas in Centre 3 the rate was 5%, with three patients developing recurrence within five years. All patients with local recurrences in Centres 2 and 3 had operations for limb salvage. Figure 4 shows the local control rate for the three centres. There were no local recurrences in the 12 patients (6.5%) who received both pre-operative chemotherapy and preoperative radiotherapy, but this did not reach statistical significance. Similarly, there was no statistical indication that pre-operative treatment reduced the rate of local recurrence. Overall survival. Overall survival for the three centres was 65% at five years and 60% at ten years from diagnosis, with the histological grade, size of the tumour and gender being significant predictive factors on univariate analysis and multivariate testing using the Cox model (Table III) . Patients with high-grade tumours had a hazard ratio of 3.5 (95% confidence interval (CI) 1.9 to 6.8) compared to low or intermediate grade tumours (p = 0.0001); those with tumours 10 cm or larger had a hazard ratio of 2.1 (p = 0.008). The overall survival was 58%, 74% and 65% at five years for all patients in Centres 1, 2 and 3, respectively (Fig. 5) . There was no significant difference between the survival rates of the three centres. The survival rates were also not affected by the use or timing of radiotherapy, nor by whether or not the patients received chemotherapy. Wound complications. Complications with the wounds occurred in 66 patients (36%) from the three centres. The chi-squared test found high grade (p = 0.046) and the size of tumour ( ≥ 10 cm) (p = 0.02) to be the only significant factors. The mean length of hospital stay of patients with wound complications was 11 days (1 to 42), significantly longer than the nine days (2 to 61) of those without complications (p = 0.04).
In Centre 1, 27 patients (42%) developed wound complications. The mean length of stay for these patients was 14 days (1 to 42), compared with eight days (3 to 23) in those patients without complications (p = 0.004).
In Centre 2, 14 patients (23%) had wound complications and their mean length of stay was 13 days (5 to 40), compared with 11 days (3 to 61) in those without. Muscle flaps were used in 33 patients, of whom 10 (30%) developed wound complications, compared with four of the 29 patients (14%) who had excision-only surgery. The chisquared test showed no difference in size (p = 0.16) and grade of tumour (p = 0.85) between the two groups. There was no relationship between wound complications and the timing of radiotherapy, with four patients (17%) having pre-or intra-operative radiotherapy suffering complications, compared with eight (30%) in the post-operative radiotherapy group (p = 0.31).
In Centre 3, 25 patients (43%) had wound complications, but this was not associated with any obvious factor. Functional outcome. The functional scores (based on 70 patients; 23 from Centre 1, and 47 from Centre 2) using the Toronto Extremity Salvage Score questionnaire averaged 77% (23% to 100%) for Centres 1 and 2. They were sig- nificantly worse for patients with wound complications (66% v 80%; p = 0.02) and high-grade tumours (69% v 85%; p = 0.0008), but they were not affected by the timing of radiotherapy (81% v 74%; p = 0.27) or the use of muscle flaps (p = 0.54).
In Centre 1, the Toronto Extremity Salvage Score showed a mean score of 73% (23% to 100%) from 23 patients, whereas in Centre 2 it had a mean score of 79% (34% to 100%) (p = 0.29). These scores were not recorded in Centre 3.
Discussion
The management of soft-tissue sarcomas of the adductor compartment remains a challenge in orthopaedic oncology owing to the large size of the tumours at diagnosis, the proximity of critical structures and the problems with wound healing at this site. We have attempted to identify whether differences in treatment affected the outcome and whether the type and timing of radiotherapy and chemotherapy influenced local control, overall survival, the incidence of wound complications and function. Several previous studies have looked at the outcomes of treatment of soft-tissue sarcomas in the limbs. [11] [12] [13] [14] [15] [16] [17] Generalising results for a limb may not be justifiable, as the nature of the anatomical compartments may influence the outcome owing to differences in vascular anatomy or lymphatic drainage. This review assesses the outcomes following resection of soft-tissue sarcoma from a single anatomical compartment.
Roughly equal numbers of patients were treated at the three centres and the groups were well matched in terms of the age of the patients and the grade of tumours. We found no difference in overall survival between the three centres, but there was a significant variation in local recurrence.
The rate of local recurrence in Centre 1 at five years was 28%, compared with 10% in Centre 2 and 5% in Centre 3. On multivariate analysis, the only factors significantly correlated to local recurrence were the margins of excision and the centre for treatment. A positive surgical margin has been shown to influence local recurrence of soft-tissue sarcoma in the limb. [18] [19] [20] [21] Statistically, the use of neither preoperative chemotherapy nor pre-operative radiotherapy seemed to be of benefit, and the margins of resection at Centres 1 and 2 were similar. Of the 184 patients, 28 were lost to follow-up before 30 months, eight each from Centres 1 and 3, and 12 from Centre 2. Assuming that all these patients had a local recurrence or died, there is still a significant increase in local recurrence in Centre 1, with no statistically significant difference in overall survival between the centres.
It is difficult to explain this difference in local control between the three centres. The tumours at Centre 1 were certainly larger than at the other two centres, and this may have compromised the ability to obtain clear margins, but this was not evident from analysis of the margins of resection. We accept that these margins may have been categorised differently in the institutional databases used in the study. This is difficult to resolve retrospectively, and represents a potential limitation of retrospective studies when an important descriptive variable influences prognosis. Another reason may be in the way in which radiotherapy treatment is planned and administered at the three centres. We have noted that in Centre 2 the same two radiation oncologists specialising in sarcomas were involved for the whole duration of the study. The procedures used included those based on the requirements of a companion randomised trial developed at the centre. Centre 3 also had a centralised service for radiotherapy. It did not have the advantage of association with a randomised trial as in Centre 2, but their margins for resection were robust. In Centre 1, patients had radiotherapy in their local hospitals with differing protocols, which were less predictable, with greater potential variation in doses, volume and fractionation. Delay in delivery of radiotherapy may adversely affect outcome. 22 We do not know whether rigorous supervision of radiotherapy does influence outcome, but it may be that the adverse impact of positive margins of resection in Centre 2 was lessened when radiotherapy was administered according to these requirements.
The surgical management of patients with soft-tissue sarcoma is best served in regionalised multidisciplinary units, 23, 24 and similar attention should be ensured when adjuvant treatments are administered at a local level. Keus et al 2 have suggested that successful local control might be related to the benefit of close co-operation between the surgeon and the radiation oncologist. Further studies comparing the outcome after treatment of this tumour between centralised specialist radiation oncology centres and local regional centres may help to clarify this.
The overall survival at five years of patients with softtissue sarcoma of the adductor compartments in the three centres was 65%. This finding is consistent with other studies, which have assessed soft-tissue sarcomas of limbs in general. 2, 25 Significant variables associated with survival on univariate and multivariate analysis were female gender, and the size and grade of the tumour. The fact that female patients survived longer than their male counterparts is interesting, with no significant difference in the grade and size of tumours between the sexes.
The timing of radiotherapy or the type of surgeon carried out did not influence the overall survival. The use of chemotherapy was not shown to be a predictive factor, even when only high-grade tumours were included. However, the study was not designed to identify any potential survival benefit of chemotherapy, and so this finding is not surprising, particularly when another large meta-analysis was not able to demonstrate benefit. 26 We found that the functional outcome was significantly worse in patients with high-grade tumours and complications with wounds, but was not associated with the timing of radiotherapy or the use of aggressive reconstructive surgery. Davis et al, 27 in a randomised trial, have also shown that the timing of radiotherapy had minimal impact on the function of these patients in the first year after surgery, and that complications with the wounds have a detrimental effect on function. Bell et al, 28 in a retrospective review of 88 patients with limb soft-tissue sarcoma have shown that large tumour size, sacrifice of a motor nerve, and wound complications were predictors of a worse functional outcome with a minimum of one-year follow-up after operation.
This large series has demonstrated that overall survival does not vary across the three international centres with different strategies for treatment. The timing of radiotherapy did not affect local recurrence or functional outcome, nor did a high grade of tumour or complications with the wounds. The higher local rate of recurrence in Centre 1 may be related to the larger size of tumour and heterogeneity of delivery of radiotherapy compared with Centre 2, where the margin of resection was similar. The retrospective nature of the study may have influenced the determination of the degree of resection at the margin owing to differences in the criteria used to assess this in the three centres. Further prospective studies should be undertaken to address the importance of centralising adjuvant treatment and a clearer international definition of margins of excision.
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